Literature DB >> 10908255

Endogenous endothelin maintains coronary artery tone by endothelin type A receptor stimulation in patients undergoing coronary arteriography.

Z S Kyriakides1, D T Kremastinos, E Bofilis, D Tousoulis, A Antoniadis, D J Webb.   

Abstract

OBJECTIVE: To examine the contribution of endothelin type A (ET(A)) receptor stimulation by endogenously generated endothelin-1 (ET-1) to the maintenance of coronary vascular tone in humans.
DESIGN: Controlled clinical study.
SETTING: Tertiary cardiovascular referral centre. PATIENTS: 14 subjects were studied, seven with normal coronary arteries and seven with coronary artery disease, mean (SEM) age, 53 (2) years.
INTERVENTIONS: After diagnostic coronary arteriography, BQ-123 (a selective ET(A) receptor antagonist; 100 nmol/min) in 0.9% saline, was infused into the left coronary artery at a rate of 1 ml/min for 60 minutes. Eight control subjects received saline alone. MAIN OUTCOME MEASURES: Blood flow velocity in the left anterior descending coronary artery, measured using a Doppler flow guidewire; coronary arteriography performed at baseline and immediately at the end of the BQ-123 or saline infusion to measure the diameter of proximal and distal left anterior descending coronary artery segments.
RESULTS: The diameter of the proximal segment increased by 6 (2)%, while that of the distal segment increased by 12 (3)% after BQ-123 (both p < 0.05 v baseline). Coronary blood flow increased from 75 (10) to 92 (10) ml/min and coronary vascular resistance decreased from 1.99 (0.36) to 1.44 (0. 22) mm Hg/ml/min after BQ-123 (both p < 0.05 v baseline). The response to BQ-123 of patients with and without coronary artery disease was similar. There was no effect of saline in the controls.
CONCLUSIONS: Endogenously produced ET-1 contributes to the maintenance of basal coronary artery tone in humans by ET(A) receptor stimulation. The role of ET(B) receptors remains to be defined.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10908255      PMCID: PMC1760920          DOI: 10.1136/heart.84.2.176

Source DB:  PubMed          Journal:  Heart        ISSN: 1355-6037            Impact factor:   5.994


  32 in total

1.  A novel potent vasoconstrictor peptide produced by vascular endothelial cells.

Authors:  M Yanagisawa; H Kurihara; S Kimura; Y Tomobe; M Kobayashi; Y Mitsui; Y Yazaki; K Goto; T Masaki
Journal:  Nature       Date:  1988-03-31       Impact factor: 49.962

2.  Assessment of short-, medium-, and long-term variations in arterial dimensions from computer-assisted quantitation of coronary cineangiograms.

Authors:  J H Reiber; P W Serruys; C J Kooijman; W Wijns; C J Slager; J J Gerbrands; J C Schuurbiers; A den Boer; P G Hugenholtz
Journal:  Circulation       Date:  1985-02       Impact factor: 29.690

3.  The effect of intracoronary injection of contrast medium upon coronary blood flow.

Authors:  M Bassan; W Ganz; H S Marcus; H J Swan
Journal:  Circulation       Date:  1975-03       Impact factor: 29.690

4.  Response of large and small coronary arteries to nitroglycerin, NaNO 2 , and adenosine.

Authors:  R L Schnaar; H V Sparks
Journal:  Am J Physiol       Date:  1972-07

5.  Cardiovascular effects of intracoronary atrial natriuretic peptide administration in man.

Authors:  H C Herrmann; A D Rosenthal; C A Davis
Journal:  Am Heart J       Date:  1990-08       Impact factor: 4.749

6.  Coronary vasodilation by nitrates is not mediated by the prostaglandin system: a quantitative cineangiographic study.

Authors:  I Simonetti; R De Caterina; C Michelassi; M Marzilli; M de Nes; A L'Abbate
Journal:  J Am Coll Cardiol       Date:  1986-12       Impact factor: 24.094

7.  Myocardial metabolic alterations after contrast angiography.

Authors:  J A Wisneski; E W Gertz; R Neese; W J Soo; J D Bristow; J R Adams; J P Beaudry
Journal:  Am J Cardiol       Date:  1982-08       Impact factor: 2.778

8.  Magnitude of dilatation of large and small coronary arteries of nitroglycerin.

Authors:  R L Feldman; C J Pepine; C R Conti
Journal:  Circulation       Date:  1981-08       Impact factor: 29.690

9.  The human endothelin family: three structurally and pharmacologically distinct isopeptides predicted by three separate genes.

Authors:  A Inoue; M Yanagisawa; S Kimura; Y Kasuya; T Miyauchi; K Goto; T Masaki
Journal:  Proc Natl Acad Sci U S A       Date:  1989-04       Impact factor: 11.205

10.  Effects of verapamil on coronary hemodynamic function and vasomobility relative to its mechanism of antianginal action.

Authors:  C Y Chew; B G Brown; B N Singh; M M Wong; C Pierce; R Petersen
Journal:  Am J Cardiol       Date:  1983-03-01       Impact factor: 2.778

View more
  15 in total

Review 1.  Role of inflammation in the regulation of coronary blood flow in ischemia and reperfusion: mechanisms and therapeutic implications.

Authors:  Jun Li; Hanrui Zhang; Cuihua Zhang
Journal:  J Mol Cell Cardiol       Date:  2011-09-05       Impact factor: 5.000

2.  Long-term administration of endothelin receptor antagonist improves coronary endothelial function in patients with early atherosclerosis.

Authors:  Martin Reriani; Eugenia Raichlin; Abhiram Prasad; Verghese Mathew; Geralyn M Pumper; Rebecca E Nelson; Ryan Lennon; Charanjit Rihal; Lilach O Lerman; Amir Lerman
Journal:  Circulation       Date:  2010-08-23       Impact factor: 29.690

3.  HIV infection and cocaine use induce endothelial damage and dysfunction in African Americans.

Authors:  Hong Tai; Hong Lai; Jayesh Jani; Shenghan Lai; Thomas S Kickler
Journal:  Int J Cardiol       Date:  2011-05-19       Impact factor: 4.164

4.  Long-term endothelin receptor antagonism attenuates coronary plaque progression in patients with early atherosclerosis.

Authors:  Myeong Ho Yoon; Martin Reriani; Gössl Mario; Charanjit Rihal; Rajiv Gulati; Ryan Lennon; Jonella M Tilford; Lilach O Lerman; Amir Lerman
Journal:  Int J Cardiol       Date:  2013-01-03       Impact factor: 4.164

5.  Physiological antagonism of endothelin-1 in human conductance and resistance coronary artery.

Authors:  K E Wiley; A P Davenport
Journal:  Br J Pharmacol       Date:  2001-06       Impact factor: 8.739

Review 6.  Working under pressure: coronary arteries and the endothelin system.

Authors:  Albert Nguyen; Nathalie Thorin-Trescases; Eric Thorin
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2010-03-17       Impact factor: 3.619

7.  Vasoconstrictor activity of novel endothelin peptide, ET-1(1 - 31), in human mammary and coronary arteries in vitro.

Authors:  J J Maguire; R E Kuc; A P Davenport
Journal:  Br J Pharmacol       Date:  2001-11       Impact factor: 8.739

Review 8.  Endothelium-derived endothelin-1.

Authors:  Eric Thorin; David J Webb
Journal:  Pflugers Arch       Date:  2009-12-05       Impact factor: 3.657

9.  Impairment of coronary endothelial cell ET(B) receptor function after short-term inhalation exposure to whole diesel emissions.

Authors:  Tom W Cherng; Matthew J Campen; Travis L Knuckles; Laura Gonzalez Bosc; Nancy L Kanagy
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2009-06-17       Impact factor: 3.619

10.  Selective endothelin A-receptor blockade attenuates coronary microvascular dysfunction after coronary stenting in patients with type 2 diabetes.

Authors:  Nikolaos Ostlund Papadogeorgos; Mattias Bengtsson; Majid Kalani
Journal:  Vasc Health Risk Manag       Date:  2009-11-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.